REX launches a new peptide ETF that looks beyond GLP-1 drugs
ETF Database covers a new fund from REX built around peptide drug makers, with a reach that goes past the GLP-1 weight loss names.
Recap by typeshit. Full story at ETF Database.
ETF Database covers a new fund from REX built around peptide drug makers, with a reach that goes past the GLP-1 weight loss names.
Recap by typeshit. Full story at ETF Database.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A quick list of foods like eggs, Greek yogurt, salmon, lentils and oats, which he says help with fullness and keeping muscle while losing weight.
Users can pick binding pockets, see predicted receptor activity and fold designs with one or more engines. Folding costs $0.10 per peptide.
Cheap Medicine Shop and Online Generic Medicine got warning letters in September for selling Semanext and Semanat injections to US buyers without approval.
Loading…